Facebook have stepped up its attack on businesses & the rate of closure of CBD & hemp pages & groups has accelerated dramatically.
- 8 comments
- Tags: Alternative health, Ban CBD, Canada, Cannabidiol, cannabis industry, Cannabis news, CBD, CBD oil, CBD Supplements, Europe, Facebook, Facebook Ban, Facebook Shadow Banning, FDA, Food & Drug Administration, Hemp, Legal cannabis, Medical cannabis, Medical Cannabis UK, MHRA, News, NHS, The Wee Hemp Company, UK Cannabis, USA
There is a lot of confusion surrounding CBD, many people are intrigued by its health & wellness properties but don’t know where to start. Clever marketing & fancy lingo can often confuse customers & put them off altogether.
As public opinion - and that of governments - changes, it seems increasingly likely that other countries will follow, raising questions about how they work together to manage the use and supply of cannabis.
One of the great mysteries surrounding cannabis has been solved. A team of scientists from the University of Toronto (U of T) has discovered how hemp & cannabis evolved from a single species—Cannabis Sativa.
Carly Barton, from Brighton, who suffers constant pain from fibromyalgia following a stroke in her 20s, was given a prescription by a private doctor who specialises in pain management.
The Wee Hemp Company's Interview with Professor Roger Pertwee | Part 2 - Cannabinoid Research HistoryPosted by Calum Napier on
Wee sat down with Professor Roger Pertwee to discuss all things CBD, the Endocannabinoid System & his extensive research history.
"We urge the medical world to get behind these reforms so they can help the tens of thousands of people who are in urgent need of help”
The move has wide-ranging implications because it recognizes the conflict between law and medicine. The proposal cites marijuana’s known medicinal properties and how existing EU prohibitions on cannabis prevent the scientific community from implementing research and treatment, particularly in a widely fractured legal regulatory environment.
NHS figures show the total for 2017-18 was £1.3bn, which is 25.7% more expensive than 10 years ago.